首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1576948

眼科設備:市場洞察·競爭環境·市場預測 (～2030年)

Ophthalmic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年10月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

眼科器械市場規模預計到 2030 年將達到 679.9 億美元，從 2023 年的 537.2 億美元增長到 2024 年至 2030 年的複合年增長率為 4.12%。

由於近視和散光等眼科疾病發病率的增加、政府改善眼睛健康的舉措不斷增加以及老年人口的增加，眼科器械市場正在迅速擴大，預計在預測期間整體市場將加速增長。至2030年。

眼科器材市場動態：

根據視覺中心 2024 年的數據，韓國、台灣和中國等國家的青少年和年輕人目前平均近視率為 84% 至 97%。全球約有 2.24 億人（近 3% 的人口）患有高度近視，而到 2050 年的預測更加令人震驚：世界上幾乎一半的人口，即 50 億人將患有近視。預計到 2050 年，高度近視的盛行率將上升到世界人口的近 10%，使約 10 億人面臨永久性視力喪失的風險。全球近視趨勢影響著數百萬人，並且由於城市化和數位化趨勢而呈上升趨勢。隨著越來越多的人患有近視，定期進行眼科檢查來診斷近視的需求也隨之增加。

此外，旨在促進眼睛健康的政府措施和眼科技術的進步也在推動市場成長。

根據世界衛生組織（WHO）2021年的數據，2015年至2050年間，60歲及以上人口將翻倍，從12%增至22%，最終到2050年，據說將達到21億人。此外，到 2030 年，六分之一的人將超過 60 歲。隨著年齡的增長，老花眼往往會加重。眼科設備對於檢測和管理與年齡相關的視力狀況（例如老花眼）也至關重要。它評估眼睛的聚焦能力，允許準確處方矯正鏡片，並幫助監測視力隨時間的變化。

本報告提供全球眼科設備的市場調查，提供市場概要，市場影響因素及市場機會分析，法律制度，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

推動市場要素
- 眼部疾病的發生率增加
- 加強政府努力改善眼睛健康
- 人口老化加劇
阻礙市場要素·課題
- 與眼科設備的使用相關的測量結果不一致
- 遠距醫療和遠距眼科檢查的進展
市場機會
- 採用光學相干斷層掃描等先進影像技術
- 開發智慧隱形眼鏡等穿戴式眼科設備

第6章眼科設備市場:波特的五力分析

第7章眼科設備市場:市場評估

各產品類型
- 外科用設備
- 診斷·監視設備
- 鏡頭
各用途
- 青光眼
- 白內障
- 視網膜症
- 老年性黃斑部病變
- 近視
- 其他
各終端用戶
- 醫院
- 專門診所
各地區
- 北美
- 歐洲
- 亞太地區
- 其他地區

第8章眼科設備市場:企業·產品簡介

Johnson & Johnson Services, Inc.
Baxter
CANON MEDICAL SYSTEMS EUROPE B.V.
CooperVision Inc.
Alcon Inc.
Bausch & Lomb, Inc.
OMRON Corporation
Ziemer Ophthalmic Systems AG
Essilor Instruments USA Ltd.
Konan Medical USA, Inc.
Optovue Incorporated
NIDEK CO. LTD.
ZEISS Group
Luneau Technology Group
OPTOPOL Technology Sp. z o.o.
Rudolf Riester GmbH
Rexxam Co. Ltd.
Keeler
Sonomed Escalon
STAAR Surgical

第9章 KOL的見解

第10章計劃的方法

第11章關於DelveInsight

第12章免責聲明與美國聯絡方式

簡介目錄圖表

Product Code: DIMDCL0464

Ophthalmic Devices Market by Product Type (Surgical Devices [Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Glaucoma Drainage Devices, Vitrectomy Systems, Excimer Lasers, Photocoagulation Lasers, and Others], Diagnostic and Monitoring Devices [Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras, Slit Lamps, Corneal Topography Systems, and Others], Lenses [Intraocular Lenses, Contact Lenses [Soft Contact Lenses and Rigid Gas Permeable Contact Lenses], Spectacle Lenses, and Others], and Others), Application (Glaucoma, Cataract, Retinopathies, Age-Related Macular Degeneration, Myopia, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the growing cases of eye-related disorders and increasing government initiatives to improve eye health worldwide

The ophthalmic devices market was valued at USD 53.72 billion in 2023, growing at a CAGR of 4.12% during the forecast period from 2024 to 2030 to reach USD 67.99 billion by 2030. The ophthalmic devices market is expanding rapidly due to the increasing incidence of eye-related disorders such as myopia, and astigmatism, increasing government initiatives to improve eye health, growing geriatric population, among others that are expected to escalate the overall ophthalmic devices market during the forecast period from 2024 to 2030.

Ophthalmic Devices Market Dynamics:

According to Vision Center (2024), currently, late teenagers and young adults in countries like Korea, Taiwan, and China suffer myopia prevalence rates ranging from 84% to 97% on average. Globally, approximately 224 million individuals, constituting nearly 3% of the population, suffer from severe myopia. The projections for 2050 are more alarming, with almost half of the world's population, constituting 5 billion people expected to be myopic. The prevalence of high myopia is anticipated to elevate for almost 10% of the global population by 2050, translating to around 1 billion individuals at risk of permanent vision impairment. The global condition of myopia, or near-sightedness, is affecting millions and is on the rise due to trends in urbanization and digitalization. This increase led researchers and healthcare professionals to explore the causes, effects, and solutions to this issue. As more people become myopic, there will be a greater need for regular eye exams to diagnose the condition.

Furthermore, government initiatives aimed at enhancing eye health, coupled with advancements in ophthalmology technology, are driving the market growth. For instance, in August 2022, The International Agency for the Prevention of Blindness (IAPB), launched a global awareness campaign by emphasizing the importance of eye care, for approximately 1 billion people worldwide lacking access to treatment for poor vision. As awareness grows about the importance of regular eye exams in maintaining eye health, there will be an increase in the number of individuals seeking eye care services. This rise in demand for eye examinations will consequently lead to an increased demand for ophthalmic devices, which are essential tools used by eye care professionals to assess refractive errors and other eye conditions during these exams.

The World Health Organization (2021) further stated that between 2015 to 2050, people above 60 years of age will be doubled from 12 to 22%, and will eventually reach 2.1 billion by the year 2050, globally. Moreover, by 2030, 1 in 6 people will be aged 60 years or above. As people age, they are more likely to develop presbyopia. Ophthalmic devices are essential in detecting and managing age-related vision conditions like presbyopia. They help assess the eye's ability to focus, enabling precise prescriptions for corrective lenses and monitoring changes in vision over time.

Therefore, the factors stated above collectively will drive the overall ophthalmic devices market growth.

However, inconsistent readings associated with the use of ophthalmic devices, advancements in telemedicine and remote eye examinations, and others may prove to be challenging factors for ophthalmic device market growth.

Ophthalmic Devices Market Segment Analysis:

In the product type segment of the ophthalmic devices market, the glaucoma drainage devices subcategory of surgical device category is expected to have a significant revenue share in the year 2023. This is because of the rising prevalence of glaucoma conditions due to increased production of aqueous humor, genetic predisposition to the condition, and other medical conditions worldwide. According to the latest data provided by the Glaucoma Research Foundation (2022), it was stated that about 80 million people were living with glaucoma worldwide with projections indicating that the stats will rise to 22 million individuals by 2040.

These devices consist of a small tube that is implanted in the eye to help drain excess aqueous humor, thereby reducing intraocular pressure (IOP). Key features of these devices include their ability to provide long-term pressure control and their compatibility with a variety of patient conditions, including those who have undergone multiple eye surgeries or have complex glaucoma cases. They are designed to minimize postoperative complications, such as hypotony (excessively low IOP), and often include mechanisms to regulate fluid flow to prevent sudden drops in pressure.

Additionally, the market key market players involved in product launches, product approvals, mergers, acquisitions, and other activities further boost the market of glaucoma drainage devices across the world. For instance, in October 2022, Alcon, the world leader in eye care committed to enabling people to see brilliantly, announced the completion of its previously announced acquisition of Ivantis(R), maker of the ground-breaking Hydrus(R) Microstent, a minimally invasive glaucoma surgery (MIGS) tool intended to reduce eye pressure for open-angle glaucoma patients in conjunction with cataract surgery.

Therefore the widespread uses and various advantages of glaucoma drainage devices enhance performance and usability, solidifying the significant impact on the growth of the overall ophthalmic devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall ophthalmic devices market:

Among all the regions, North America is expected to dominate the ophthalmic devices market in the year 2023 and is expected to do the same during the forecast period from 2024 to 2030. This is driven by the presence of a significant number of eye care professionals and clinics, including optometrists, ophthalmologists, and eye care centers, a large patient pool associated with vision loss, hypermetropia, and astigmatism, the presence of a developed & sophisticated healthcare infrastructure, and product developmental activities are factors that drive the expansion of the ophthalmic devices market in the North America region during the forecast period from 2024 to 2030.

According to the American Academy of Ophthalmology (2024), 33% of people in the US have astigmatism. Astigmatism affects people of all ages and races. Babies may even have astigmatism, although most soon outgrow it. Additionally, it stated that 14 million Americans aged 40 and above are affected with hypermetropia. Ophthalmic devices are essential in diagnosing and managing astigmatism and hypermetropia by analyzing how light interacts with the eye. Refractometers and autorefractors measure light refraction to detect vision imperfections, while corneal topography maps the curvature of the cornea to identify irregularities. Phoropters are used during eye exams to determine the correct lens prescription, aiding in the treatment of these conditions.

According to statistics unveiled by the Canadian Council of the Blind in February 2022, approximately 1.2 million Canadians suffered vision loss in 2020. Projections for the year 2030 estimate that this figure will surge to 1.58 million. Such increase in the number of cases of vision impairment are anticipated to fuel the uptake of visual impairment devices, consequently influencing market dynamics in the region. As awareness of eye health grows in response to the rising prevalence of vision loss, there may be a greater emphasis on preventive care and early detection of eye conditions. Ophthalmic devices play a vital role in vision loss and improving eye health. These devices are used for early detection, diagnosis, and treatment of eye conditions, helping to prevent further deterioration and improve the quality of life for individuals with visual impairments. As awareness of eye health increases, the demand for these devices is expected to grow, enhancing the overall approach to eye care and preventive measures in the region.

Rising product developmental activities by regulatory bodies and key players in the region will further boost the market for ophthalmic devices. For example, in October 2021, iCare USA received the 510k approval from the U.S Food and Drug Administration for their EIDON Ultra-Widefield Lens module which is capable of capturing 120 degrees images of the retina in a single shot or in mosaic function mode, images up to 200 degrees.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American ophthalmic devices market.

Ophthalmic Devices Market key players:

Some of the key market players operating in the ophthalmic devices market include Johnson & Johnson Services, Inc., Baxter, CANON MEDICAL SYSTEMS EUROPE B.V., CooperVision Inc., Alcon Inc., Bausch & Lomb, Inc., OMRON Corporation, Ziemer Ophthalmic Systems AG, Essilor Instruments USA Ltd., Konan Medical USA, Inc., Optovue Incorporated, NIDEK CO. LTD., ZEISS Group, Luneau Technology Group, OPTOPOL Technology Sp. z o.o., Rudolf Riester GmbH, Rexxam Co. Ltd., Keeler, Sonomed Escalon, STAAR Surgical, and others.

Recent Developmental Activities in the Ophthalmic Devices Market:

In February 2024, RetinAI, a provider of software solutions for image processing and artificial intelligence in ophthalmology, introduced the RetinAI Discovery for Clinics platform. The platform was launched in both ophthalmology and optometry versions.
In November 2023, Lumenis announced the launch of OptiPlus, its new dual-frequency radiofrequency device designed to deliver heat across various tissue layers, aimed at increasing blood circulation and addressing dry eye inflammation caused by meibomian gland dysfunction.
In October 2021, NIDEK CO LTD. launched the Retina Scan Duo 2, a combined OCT and fundus camera system. The system comes equipped with new features designed to enhance screening and clinical efficiency.
In May 2021, Essilor International received the product approval from the US FDA for their product Essilor Stellest which is a spectacle lens developed for the correction of myopia and slowing down myopia progression in children.

Key Takeaways from the Ophthalmic Devices Market Report Study

Market size analysis for current ophthalmic devices market size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the ophthalmic devices market.
Various opportunities available for the other competitors in the ophthalmic devices market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current ophthalmic devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for ophthalmic devices market growth in the coming future?

Target Audience who can be benefited from this Ophthalmic Devices Market Report Study

Ophthalmic devices product providers
Research organizations and consulting companies
Ophthalmic devices-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in ophthalmic devices
Various end-users who want to know more about the ophthalmic devices market and the latest technological developments in the ophthalmic devices market

Frequently Asked Questions for the Ophthalmic Devices Market:

1. What are Ophthalmic Devices?

The ophthalmic devices help in the diagnosis and treatment of ocular diseases by helping in the visualization of the anatomy of eye and treating the indication in by being utilized in different aspects of disease diagnosis and treatment.

2. What is the market for Ophthalmic Devices?

The ophthalmic devices market was valued at USD 53.72 billion in 2023, growing at a CAGR of 4.12% during the forecast period from 2024 to 2030 to reach USD 67.99 billion by 2030.

3. What are the drivers for the Ophthalmic Devices market?

The ophthalmic devices market is expanding rapidly due to the increasing incidence of eye-related disorders such as myopia, and astigmatism, increasing government initiatives to improve eye health, growing geriatric population, among others that are expected to escalate the overall ophthalmic devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Ophthalmic Devices market?

Some of the key market players operating in ophthalmic devices include Johnson & Johnson Services, Inc., Baxter, CANON MEDICAL SYSTEMS EUROPE B.V., CooperVision Inc., Alcon Inc., Bausch & Lomb, Inc., OMRON Corporation, Ziemer Ophthalmic Systems AG, Essilor Instruments USA Ltd., Konan Medical USA, Inc., Optovue Incorporated, NIDEK CO. LTD., ZEISS Group, Luneau Technology Group, OPTOPOL Technology Sp. z o.o., Rudolf Riester GmbH, Rexxam Co. Ltd., Keeler, Sonomed Escalon, STAAR Surgical, and others.

5. Which region has the highest share in the Ophthalmic Devices market?

North America is expected to dominate the overall ophthalmic devices market during the forecast period from 2024 to 2030. This is driven by the presence of a significant number of eye care professionals and clinics, including optometrists, ophthalmologists, and eye care centers, a large patient pool associated with vision loss, hypermetropia, and astigmatism, the presence of a developed & sophisticated healthcare infrastructure, and product developmental activities are factors that drive the expansion of the ophthalmic devices market in the North America region during the forecast period from 2024 to 2030.

1. Ophthalmic Devices Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Ophthalmic Devices Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Ophthalmic Devices Market Key Factors Analysis

5.1. Ophthalmic Devices Market Drivers
- 5.1.1. Increasing incidence of eye disorders
- 5.1.2. Increasing Government initiatives to improve eye health
- 5.1.3. Rising geriatric population
5.2. Ophthalmic Devices Market Restraints and Challenges
- 5.2.1. Inconsistent readings associated with the use of ophthalmic devices
- 5.2.2. Advancements in telemedicine and remote eye examinations
5.3. Ophthalmic Devices Market Opportunities
- 5.3.1. Incorporating advanced imaging techniques like optical coherence tomography
- 5.3.2. Development of wearable ophthalmic devices, like smart contact lenses

6. Ophthalmic Devices Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Ophthalmic Devices Market Assessment

7.1. By Product Type
- 7.1.1. Surgical Devices
  - 7.1.1.1. Phacoemulsification Devices
  - 7.1.1.2. Ophthalmic Viscoelastic Devices
  - 7.1.1.3. Glaucoma Drainage Devices
  - 7.1.1.4. Vitrectomy Systems
  - 7.1.1.5. Excimer Lasers
  - 7.1.1.6. Photocoagulation Lasers
  - 7.1.1.7. Others
- 7.1.2. Diagnostic and Monitoring Devices
  - 7.1.2.1. Optical Coherence Tomography Systems
  - 7.1.2.2. Ophthalmic Ultrasound Systems
  - 7.1.2.3. Fundus Cameras
  - 7.1.2.4. Slit Lamps
  - 7.1.2.5. Corneal Topography Systems
  - 7.1.2.6. Others
- 7.1.3. Lenses
  - 7.1.3.1. Soft Contact Lenses
  - 7.1.3.1.1. Soft Contact Lenses
  - 7.1.3.1.2. Rigid Gas Permeable Lenses
  - 7.1.3.2. Spectacle Lenses
  - 7.1.3.3. Others
7.2. By Application
- 7.2.1. Glaucoma
- 7.2.2. Cataracts
- 7.2.3. Retinopathies
- 7.2.4. Age-related Macular Degeneration
- 7.2.5. Myopia
- 7.2.6. Others
7.3. By End-User
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Others
7.4. By Geography
- 7.4.1. North America
  - 7.4.1.1. United States Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.1.2. Canada Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.1.3. Mexico Ophthalmic Devices Market Size in USD million (2021-2030)
- 7.4.2. Europe
  - 7.4.2.1. France Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.2.2. Germany Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.2.3. United Kingdom Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.2.4. Italy Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.2.5. Spain Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.2.6. Rest of Europe Ophthalmic Devices Market Size in USD million (2021-2030)
- 7.4.3. Asia-Pacific
  - 7.4.3.1. China Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.3.2. Japan Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.3.3. India Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.3.4. Australia Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.3.5. South Korea Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.3.6. Rest of Asia-Pacific Ophthalmic Devices Market Size in USD million (2021-2030)
- 7.4.4. Rest of the World (RoW)
  - 7.4.4.1. Middle East Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.4.2. Africa Ophthalmic Devices Market Size in USD million (2021-2030)
  - 7.4.4.3. South America Ophthalmic Devices Market Size in USD million (2021-2030)

8. Ophthalmic Devices Market Company and Product Profiles

8.1. Johnson & Johnson Services, Inc.
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Baxter
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. CANON MEDICAL SYSTEMS EUROPE B.V.
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. CooperVision Inc.
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Alcon Inc.
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. Bausch & Lomb, Inc.
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. OMRON Corporation
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Ziemer Ophthalmic Systems AG
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Essilor Instruments USA Ltd.
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Konan Medical USA, Inc.
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Optovue Incorporated
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. NIDEK CO. LTD.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. ZEISS Group
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Luneau Technology Group
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. OPTOPOL Technology Sp. z o.o.
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. Rudolf Riester GmbH
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. Rexxam Co. Ltd.
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. Keeler
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Sonomed Escalon
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. STAAR Surgical
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy